Edition:
India

Monster Digital Inc (MSDI.OQ)

MSDI.OQ on NASDAQ Stock Exchange Capital Market

0.61USD
12 Dec 2017
Change (% chg)

$0.00 (+0.49%)
Prev Close
$0.61
Open
$0.61
Day's High
$0.62
Day's Low
$0.61
Volume
11,242
Avg. Vol
76,711
52-wk High
$3.51
52-wk Low
$0.40

Chart for

About

Monster Digital, Inc. designs and engineers data storage and memory products. The Company is engaged in the design, development and marketing of its products under the Monster Digital brand for use in high-performance computing and consumer and mobile product applications. The Company's primary product offerings include an... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $5.77
Shares Outstanding(Mil.): 9.34
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 23,441.23 16.44
EPS (TTM): -- -- --
ROI: -- 4.15 10.62
ROE: -- 6.83 14.20

BRIEF-Monster Digital Receives Requested Extension From Nasdaq Panel

* MONSTER DIGITAL RECEIVES REQUESTED EXTENSION FROM NASDAQ PANEL

3:01am IST

BRIEF-Monster Digital Terminates License Deal Between Monster Inc, SDJ Technologies

* HAS FORWARDED MONSTER INC A NOTICE OF TERMINATION OF TRADEMARK LICENSE DEAL BETWEEN MONSTER INC, SDJ TECHNOLOGIES

05 Dec 2017

BRIEF-Monster Digital provides update regarding closing date for merger with Innovate Biopharmaceuticals

* MONSTER DIGITAL, INC. PROVIDES UPDATE REGARDING ANTICIPATED CLOSING DATE FOR MERGER WITH INNOVATE BIOPHARMACEUTICALS, INC.

30 Nov 2017

BRIEF-MONSTER DIGITAL ANNOUNCES EXTENSION OF OFFERS TO AMEND AND EXERCISE WARRANTS

* MONSTER DIGITAL INC ANNOUNCES EXTENSION OF OFFERS TO AMEND AND EXERCISE WARRANTS

17 Nov 2017

BRIEF-Monster Digital announces extension of offer to amend and exercise warrants

* Monster Digital announces change to date of special meeting and extension of offer to amend and exercise warrants

13 Oct 2017

BRIEF-Monster Digital announces filing of preliminary proxy statement for proposed merger with Innovate Biopharmaceuticals

* Monster Digital announces filing of preliminary proxy statement for proposed merger with Innovate Biopharmaceuticals Source text for Eikon: Further company coverage:

26 Aug 2017

BRIEF-Monster Digital reports Q2 loss per share $0.19

* Q2 net sales $187,000 versus $1.7 million Source text: (http://bit.ly/2fZSIxX) Further company coverage:

22 Aug 2017

BRIEF-Monster digital inc files for non-timely 10-Q - SEC filing‍​

* Monster Digital Inc files for non-timely 10-Q - sec filing‍​ Source text - (http://bit.ly/2fI3zfV) Further company coverage:

15 Aug 2017

BRIEF-Monster Digital and Innovate Biopharmaceuticals sign merger agreement

* Monster Digital and Innovate Biopharmaceuticals sign merger agreement

03 Jul 2017

BRIEF-MONSTER DIGITAL ANNOUNCES RECEIPT OF NASDAQ NOTICE OF BID PRICE DEFICIENCY

* MONSTER DIGITAL ANNOUNCES RECEIPT OF NASDAQ NOTICE OF BID PRICE DEFICIENCY Source text for Eikon: Further company coverage:

20 Jun 2017

Earnings vs. Estimates

No consensus analysis data available.